Darrell Tan

Infectious Diseases
Tel: 416-864-6060 x77505
Fax: 416-864-5310
Email: darrell.tan@gmail.com

Clinician Scientist 
Assoc Professor

Dr. Tan is an infectious diseases physician, clinician-scientist and CIHR New Investigator whose research focuses on clinical trials in HIV prevention and HIV/STI co-infection. As Director of the University of Toronto Clinical Research Unit on HIV Prevention and co-leader of the CIHR Canadian HIV Trials Network Biomedical Prevention Working Group, he is leading multiple efforts to optimize the implementation of HIV pre- and post-exposure prophylaxis (PrEP and PEP) in Canada. These include Canada’s first demonstration project of daily oral TDF/FTC-based PrEP in Toronto MSM, the development of national Clinical Practice Guidelines on PEP & PrEP use, exploration of the relationship between syndemic health problems and clinical outcomes of PEP & PrEP, studies of nurse-led PEP & PrEP, and evaluations of novel antiretroviral PEP regimens. Additional research interests are in the interaction between HIV and common co-infections such as herpes simplex virus type 2 (HSV-2) and syphilis, and the role of systemic inflammation in driving clinical outcomes in people living with HIV. He is also Co-PI on two CIHR-supported multicentre RCTs including the a trial of anti-herpes medication for attenuating HIV disease progression, and a trial of enhanced syphilis screening in HIV-positive men.

Email: darrell.tan@gmail.com | Tel: 416-864-5568